ABANATUSS PED (KRAMER NOVIS)


Welcome to the PulseAid listing for the ABANATUSS PED drug offered from KRAMER NOVIS. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: KRAMER NOVIS
NON-PROPRIETARY NAME: CHLOPHEDIANOL HYDROCHLORIDE, DEXCHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE
SUBSTANCE NAME: CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2015-07-01
END MARKETING DATE: 0000-00-00


ABANATUSS PED HUMAN OTC DRUG Details:

Item DescriptionABANATUSS PED from KRAMER NOVIS
LABELER NAME: KRAMER NOVIS
DEA SCHEDULE:
ACTIVE STRENGTH: 25; 2; 60(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2015-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52083-675_bb2fe455-c804-484e-93ba-2ae09e9ccbaf
PRODUCT NDC: 52083-675
APPLICATION NUMBER: part341

Other CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GM PharmaceuticalsVANACOF
KRAMER NOVISABANATUSS PED
Seyer Pharmatec, Inc.Panatuss PED